Interest Groups

$1 Billion Settlement in Defective Hip Implant Litigation - Litigation News

Get the news you want the way you want it: click the RSS button in the right corner to add this feed to your RSS reader, or click here to subscribe to this content. By subscribing, you’ll find this news on your Member Account page, and the latest articles will be emailed to you in your customized IndyBar E-Bulletin e-newsletter.

Litigation News

Posted on: Nov 5, 2014

By Timothy F. Devereux, Ladendorf Law

A federal multidistrict litigation (MDL) involving more than 2,375 plaintiffs in 39 states and a New Jersey state court action involving over 2,000 more cases against defective hip replacement devices from the Stryker Orthopaedics has been settled for over $1 billion. The settlement, which was announced to involved counsel late Monday, November 3, 2014, will apply to victims who already required revision surgery to remove the faulty hardware and have it replaced. The settlement amounts to approximately $300,000 per patient. While this phase of the litigation is over, the litigation will continue for those individuals who have the device implanted in them and have not yet had the surgery to replace it.

Howmedica and Stryker had its Rejuvenate and ABG II Modular Hip Implant devices recalled in July 2012 amid reports of unusually high rates of device failure. An estimated 20,000 people were implanted in the U.S. with the Rejuvenate and ABG II hip products.

For more information, click here.

This article was written by Timothy F. Devereux, Ladendorf Law. If you would like to submit content or write an article for the Litigation Section page, please email Mary Kay Price at


Indianapolis Bar Association (IndyBar) est. 1878 | 4,536 Members (as of 2.11.21)